Kantor, Olga
Wong, Stephanie
Weiss, Anna
Metzger, Otto
Mittendorf, Elizabeth A.
King, Tari A.
Article History
Received: 18 December 2019
Accepted: 22 July 2020
First Online: 13 August 2020
Competing interests
: T.A.K.—Speaker’s fee for Exact Sciences (formally Genomic Health) and advisory board role for Exact Sciences (formally Genomic Health). E.A.M.—Participation in scientific advisory boards for Exact Sciences (formally Genomic Health) and Merck; clinical trial funding from Genetech via SU2C. The remaining authors declare no competing interests.